160 related articles for article (PubMed ID: 37898816)
1. Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation.
Frese-Schaper M; Voll RE; Frese S
BMC Res Notes; 2023 Oct; 16(1):298. PubMed ID: 37898816
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
[TBL] [Abstract][Full Text] [Related]
3. The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis.
Keil A; Frese-Schaper M; Steiner SK; Körner M; Schmid RA; Frese S
Arthritis Rheumatol; 2015 Jul; 67(7):1858-67. PubMed ID: 25779651
[TBL] [Abstract][Full Text] [Related]
4. Low-dose irinotecan improves advanced lupus nephritis in mice potentially by changing DNA relaxation and anti-double-stranded DNA binding.
Frese-Schaper M; Keil A; Steiner SK; Gugger M; Körner M; Kocher GJ; Schiffer L; Anders HJ; Huynh-Do U; Schmid RA; Frese S
Arthritis Rheumatol; 2014 Aug; 66(8):2259-69. PubMed ID: 24729466
[TBL] [Abstract][Full Text] [Related]
5. The endoplasmic reticulum stress-inducible protein, Herp, is a potential triggering antigen for anti-DNA response.
Hirabayashi Y; Oka Y; Ikeda T; Fujii H; Ishii T; Sasaki T; Harigae H
J Immunol; 2010 Mar; 184(6):3276-83. PubMed ID: 20147634
[TBL] [Abstract][Full Text] [Related]
6. Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages.
Zhang H; Fu R; Guo C; Huang Y; Wang H; Wang S; Zhao J; Yang N
J Transl Med; 2016 Jun; 14(1):156. PubMed ID: 27250627
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide cleavage and rejoining by topoisomerase III from the hyperthermophilic archaeon Sulfolobus solfataricus: temperature dependence and strand annealing-promoted DNA religation.
Chen L; Huang L
Mol Microbiol; 2006 May; 60(3):783-94. PubMed ID: 16629677
[TBL] [Abstract][Full Text] [Related]
9. Lupus autoantibodies to native DNA preferentially bind DNA presented on PolIV.
Kumar S; Bunting KA; Kalsi J; Hinks JA; Latchman DS; Pearl LH; Isenberg DA
Immunology; 2005 Mar; 114(3):418-27. PubMed ID: 15720443
[TBL] [Abstract][Full Text] [Related]
10. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice.
Fredriksen K; Osei A; Sundsfjord A; Traavik T; Rekvig OP
Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573
[TBL] [Abstract][Full Text] [Related]
11. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus.
Sun Y; Fong KY; Chung MC; Yao ZJ
Int Immunol; 2001 Feb; 13(2):223-32. PubMed ID: 11157855
[TBL] [Abstract][Full Text] [Related]
12. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
14. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
16. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus.
Zack DJ; Yamamoto K; Wong AL; Stempniak M; French C; Weisbart RH
J Immunol; 1995 Feb; 154(4):1987-94. PubMed ID: 7836777
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring V region connected antibodies inhibit anti-dsDNA antibody reactivity with dsDNA.
Srdic-Rajic T; Jurisic V; Andrejevic S; Bonaci-Nikolic B; Bowker T; Concas D; Metlas R
Immunobiology; 2012 Jan; 217(1):111-7. PubMed ID: 21840618
[TBL] [Abstract][Full Text] [Related]
18. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
Wang X; Xia Y
Front Immunol; 2019; 10():1667. PubMed ID: 31379858
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
20. A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus.
Lindorfer MA; Schuman TA; Craig ML; Martin EN; Taylor RP
J Immunol Methods; 2001 Feb; 248(1-2):125-38. PubMed ID: 11223074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]